Nemes Rush Group’s Boston Scientific BSX Stock Holding History

Nemes Rush Group’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$950K	Buy	22,269 +4,394	+25%	+$239K	0.08%	114
2026 Q1	$1.12M	Buy	17,875 +613	+4%	+$49K	0.11%	99
2025 Q4	$1.65M	Sell	17,262 -2,841	-14%	-$279K	0.15%	84
2025 Q3	$1.96M	Buy	20,103 +77	+0.4%	+$7.97K	0.19%	77
2025 Q2	$2.15M	Buy	20,026 +19,391	+3,054%	+$1.96M	0.23%	75
2025 Q1	$64.1K	Hold	635	–	–	0.01%	288
2024 Q4	$56.7K	Buy	635 +481	+312%	+$42.3K	0.01%	291
2024 Q3	$10.5K	Hold	154	–	–	﹤0.01%	395
2024 Q2	$11.9K	Sell	154 -613	-80%	-$44.9K	﹤0.01%	393
2024 Q1	$52.5K	Hold	767	–	–	0.01%	267
2023 Q4	$44.3K	Hold	767	–	–	0.01%	270
2023 Q3	$40.5K	Buy	767 +154	+25%	+$8.08K	0.01%	274
2023 Q2	$33.2K	Buy	+613	New	+$32K	0.01%	310

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Nemes Rush Group's BSX Position: Q2 2026 in Review

Nemes Rush Group increased its Boston Scientific (BSX) stake by 25% in Q2 2026, buying an estimated $239K and bringing the position to 22,269 shares worth $950K. The position accounts for 0.08% of the portfolio, ranked #114.

Nemes Rush Group first reported a position in BSX in Q2 2023 and has held it in 13 quarters since. The position peaked at $2.15M in Q2 2025. 1,479 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Nemes Rush Group held 22,269 shares of Boston Scientific worth $950K as of Q2 2026.
Nemes Rush Group bought 4,394 Boston Scientific shares in Q2 2026, an estimated $239K.
Boston Scientific made up 0.08% of Nemes Rush Group's portfolio in Q2 2026, its #114 holding.
Nemes Rush Group first reported a position in Boston Scientific in Q2 2023 and has held it in 13 quarters since.
Nemes Rush Group's Boston Scientific position peaked at $2.15M in Q2 2025.
1,479 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Nemes Rush Group's 13F filing for Q2 2026, filed 14 Aug 2026.